Botox maker to pay $600M to resolve investigation
Thursday, September 2, 2010 - 03:35
in Mathematics & Economics
(AP) -- Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.